China General Technology (Group) Holding Co., Ltd. (hereinafter referred to as the “Group”) is an important state-owned enterprise directly managed by the central government. It was established in March 1998 and is a state-owned sole proprietorship company formed on the basis of six former enterprises of the former Ministry of Foreign Trade and Economic Cooperation. Since 2006, the Group has reorganized five central enterprises and some local key enterprises. The group implements the parent-subsidiary company's management structure, with the characteristics of small headquarters, large networks, light assets, and internationalization. At present, the Group has 21 domestic secondary operating agencies, including three listed companies (China Pharmaceutical 600056.SH, China Steam Weak 601965.SH, Global Medical 02666.HK); it has 63 overseas institutions.
The Group is in a completely market-oriented and fully competitive field. Its core business includes trade and engineering contracting, medicine and health industry, technical service consulting and advanced manufacturing. It has a full range of professional talents with high quality and rich experience, and has long-term and stable strategic cooperation relationships with many large international and domestic enterprises and financial institutions. Most of the main subsidiaries of each sector have a history of more than half a century. They have strong capabilities, complete qualifications, and outstanding brand reputation. They play an important role in China's related industries or segments and have made important contributions to economic and social development for a long time.
In the field of trade and engineering contracting , the Group as a whole has strong international market development capabilities, business integration service capabilities, global resource integration capabilities, international project management capabilities and risk management and control capabilities. The Group is the main channel for the introduction of major national technological equipment. It has accumulated more than US$340 billion in advanced technology and complete sets of equipment for all walks of life in the country for more than 60 years; it has vigorously implemented the “going out” strategy and is deeply involved in the construction of “One Belt and One Road” to drive China’s standards. , China's technology, and Chinese equipment go global, accumulatively completed 11 billion U.S. dollars in international project contracting revenue in the areas of power energy, rail transit, and infrastructure; and implemented international capacity cooperation projects with more than 20 countries and regions in the world, involving light industrial textiles, Chemicals building materials, ships and other fields; has a strong domestic and international integrated operating capabilities and a better domestic and international marketing network, logistics and distribution network, and the world's more than 100 countries and regions have established a stable trade cooperation.
In the medical and health industry sector , the Group is one of the three central enterprises approved by the SASAC for the pharmaceutical industry. Its business scope covers the pharmaceutical industry, pharmaceutical and commerce, pharmaceutical import and export, medical finance, hospital investment and construction, medical technology services, and medical care. In the field of informatization, a relatively complete industrial chain has been formed, and medical and pharmaceutical businesses rank among the top in the country. It can provide hospital clients with comprehensive medical services that integrate financing, equipment, technology and training. With more than 1,000 hospital customers and more than 60 international top medical institution partners, it has become a leading large-scale comprehensive medical service provider in China.
In the field of technical service consulting and advanced manufacturing , they have key enterprises and research institutes in industries such as automotive, textile, precision ultra-precision CNC machine tools, precision measuring tools, and environmental consulting. Relying on 38 national and provincial R&D institutions (including 10 national-level institutions), 6 post-doctoral workstations, 36 production and research platforms and 2 passenger space, and undertaking major national science and technology projects and key scientific and technological projects in the past five years. The project has won 81 national and provincial-level scientific and technological awards and 434 invention patents. It has conquered a number of industry common technologies and key technologies, revised a number of related industry international and national standards, and played a leading and supporting role for the industry. , Forming a good situation for the coordinated development of scientific research and industrialization.
The Group has been awarded Grade A for eight consecutive years (2009-2016) in the performance evaluation of central enterprises, and won the “Outstanding Enterprise Award” for two consecutive terms. The group leadership team was rated as outstanding in the comprehensive assessment of the 2013-2015 tenure of the leadership team of China National Management Corporation. From 2014, it has entered Fortune Global 500 for 4 consecutive years. Since 2012, ENR has been in ENR's list of the world's largest international contractors for six consecutive years.
Facing the future, they will follow the party's spirit of the Nineteenth National Congress to implement the socialist ideology with Chinese characteristics in the new era of Jinping and continue to practice the new concept of development.Theye will focus on serving the national “One Belt and One Road” initiative and the healthy China strategy, and vigorously develop strategies. Emerging industries, deepening reform, innovation-driven, structural adjustment, transformation and upgrading, and strive to build the Group into a world-class enterprise with global competitiveness.
